Eli Lilly Unveils State-of-the-Art Genetic Medicine Research Center in Boston

Location and Purpose:
Eli Lilly has opened a new research and development center in Boston's Seaport neighborhood, focusing on genetic medicines.

Facility Details:
The center is a 12-story, 346,000-square-foot building, representing a $700 million investment.

Functionality:
The center will serve as a central hub for Lilly's genetic medicines efforts and will house laboratories and office space for medicine development.

Workforce Expansion:
The new facility will accommodate Lilly's expanding workforce in Massachusetts.

Announcement and Opening:
The center was first announced in 2022 and officially opened on Tuesday, August 13, 2024.